This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: PBM Industry Update: Trends, Challenges, and What's Ahead This event will be broadcast live on Friday, April 4, 2025, from 12:00 p.m. This event is part of The Drug Channels 2025 Video Webinar Series.
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. This week, I’m attending Asembia’s SpecialtyPharmacy Summit. Click here to see the original post from May 2022. d/b/a Drug Channels Institute.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBM Industry Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. Broadcast live on April 22, 2022 , from 12:00 p.m. to 1:30 p.m.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2023. The webinar will be broadcast from the Drug Channels studio in beautiful downtown Philadelphia. The webinar will last 90 minutes to accommodate audience questions.
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Last week, we documented the substantial concentration of dispensing revenues for specialty drugs. Click here to see the original post from April 2024. All rights reserved.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2022. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. The Outlook 2022 marks our third annual outlook webinar. Broadcast live on December 17, 2021.
Launched in 2019, NABP’s SpecialtyPharmacy Accreditation was created to accredit pharmacies providing advanced levels of pharmacy services and disease management tools for patients taking medications that require special handling, storage, and dispensing requirements.
In this issue: The State of SpecialtyPharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble Reconsidering Amazon P.S. Please join the nearly 13,000 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter. Happy Thanksgiving, everyone!
This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. For updated data on hospital-owned specialtypharmacies, see Chapter 3 of DCI's new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.
In May, I recorded a brief video webinar for an on-demand business education session at Asembia's 2020 SpecialtyPharmacy Summit Virtual Experience. You can watch the full video below.
Please join me for my upcoming live video webinar, Drug Channels Outlook 2022 , on December 17, 2021, from 12:00 p.m. Happy Thanksgiving, everyone! Before you stretch your stomach, stretch your mind with our extra-stuffed helping of food for thought. to 1:30 p.m.
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Update: Buy-and-Bill Market Trends. In Drug Channels Institute's list of the top 15 pharmacies of 2020 , we show that many of the largest U.S. Click here to see the original post and comments from May 2021.
I received good feedback on Tuesday's video about retail pharmacy. So below, you'll find another brief video excerpt from my May 1 Industry Update and COVID-19 Impact video webinar. In this clip, I highlight the growth and consolidation dynamics facing the specialtypharmacy industry.
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. billion figure was roughly accurate for the AllianceRx Walgreens Pharmacy business. Consequently, its market share is closer to 10%, compared with the 3% that we reported.
In this issue: The State of SpecialtyPharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble CVS acknowledges how its PBM profits from 340B Reconsidering Amazon Plus, the FDA preps you for Thursday with a regulatory soup review. Happy Thanksgiving, everyone! to 1:30 p.m.
This week, I’m rerunning some popular posts while I prepare for today's video webinar: Drug Channels Outlook 2021. Will COVID-19 trigger long-term share gains for specialtypharmacies as suppliers to hospitals and physician offices? Click here to see the original post and comments from September 2020.
In Drug Channels Institute's list of the top 15 pharmacies of 2019 , we show that many of the largest U.S. pharmacies are now central-fill mail and specialtypharmacies operated by PBMs and insurers. I see upside for specialtypharmacies in the aftermath of the pandemic. d/b/a Drug Channels Institute.
Consolidation has brought together large, economically significant insurer/PBM/specialtypharmacy/provider organizations within U.S. If this clip whets your appetite for more, purchase a replay of the full 90 minute Drug Channels Outlook 2023 video webinar. Or register for my forthcoming 2023 video webinar series.
This week, Im rerunning some popular posts while I prepare for todays Drug Channels Outlook 2025 live video webinar. (If Like it or not, vertically integrated insurers, PBMs, specialtypharmacies, and providers will continue to prosper. If you sign up before 12 p.m. ET, you can attend the live event.) spending on healthcare.
PCMA’s PBM Members send a large number of executives from relevant business units including pharma and trade relations, specialtypharmacy, clinical and patient care services, and the c-suite. The PCMA Business Forum is PCMA's largest business networking and educational conference.
Stacey discusses how a patient support vendor can help specialtypharmacy patients attain prior authorizations and access critical therapies. Learn more about AssistRx’s technology and patient support services by viewing their on-demand webinars. Read on for Stacey’s insights. d/b/a Drug Channels Institute.
This week, I’m rerunning some popular posts while I prepare for Fiday's Drug Channels Outlook 2024 live video webinar. For 2023, specialtypharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs.
The largest 15 pharmacies accounted for more than 75% of total dispensing revenues from retail, mail, long-term care, and specialtypharmacies. The top 15's share dipped slightly compared with their 2021 share, due primarily to the significant revenue losses for Walgreens Boots Alliance’s AllianceRx Walgreens Pharmacy.
Please join me for my upcoming live video webinar, Drug Channels Outlook 2022 , on December 17, 2021, from 12:00 p.m. Happy Thanksgiving, everyone! Before you stretch your stomach, stretch your mind with our extra-stuffed helping of food for thought. to 1:30 p.m.
Federal grantees are aligned primarily with the vertically intergated organizations' retail pharmacies, while hospitals rely on mail and specialtypharmacies. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J. Fein, Ph.D., All rights reserved.
Federal grantees are aligned primarily with the vertically intergated organizations' retail pharmacies, while hospitals rely on mail and specialtypharmacies. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J. Fein, Ph.D., All rights reserved.
This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Drug Channels Outlook 2021. Last week, news broke that Prime Therapeutics is expanding its relationship with Cigna’s Express Scripts to include mail and specialtypharmacy dispensing.
My recent tweets have highlighted: doctors against step therapy, distribution of COVID-19 therapies, biosimilar savings, copay accumulator data, prospects for smaller PBMs, the new transparency rule, specialtypharmacy profit metrics, the future of oncology practices, and an update on Diplomat founder Phil Hagerman. to 1:15 p.m.
As you will see below, mail and specialtypharmacies’ purchases of products that are eligible for 340B discounts have grown by an incredible 56% per year since 2017. That’s about six times faster than the overall mail and specialty market. Consequently, specialtypharmacies have gained a greater share of the 340B market.
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Update: 340B Controversies and Outlook. Pharmacies and Pharmacy Benefit Managers. Click here to see the original post and comments from March 2021. prescription dispensing revenues for calendar year 2020.
The largest players all had bigger slices of the revenue pie, due to the growth at specialtypharmacies and multiple transactions that shifted market share among the vertically integrated companies. The exhibit below—one of 211 in our new report—provides a first look at the 15 largest organizations, ranked by total U.S. to 1:30 p.m.
Clarify What Information is Sought from Speakers Report on Data Utilization Host Educational Webinars Before Listening Sessions Market as Stakeholder Listening Sessions if They Have Broader Representation Improve the Structure of the Listening Sessions. Pharmacy benefit managers: transparency, accountability, and impact on patient care.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , for his latest exclusive live video webinar: Drug Channels Quarterly Update: Patients, Payers, and PBMs Friday, March 26, 2021 (12:00 p.m. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. to 1:30 p.m. WHAT YOU WILL LEARN.
For 2024, DCI estimates that total prescription dispensing revenues at retail, mail, long-term care, and specialtypharmacies reached $683 billion, up 9% from the 2023 figure. Will PBMs be able to maintain their position as the leading pharmacies? drug pricing, reimbursement, and dispensing system. to 1:30 p.m.
This week, Im rerunning some popular posts while I prepare for tomorrows Drug Channels Outlook 2025 live video webinar. During the webinar, I'll share some thoughts on how vertical integration will affect the buy-and-bill channel. Click here to see the original post from September 2024. drug channels.
Want to bundle the report with DCIs video webinars ? Weve updated all market and industry data with the most current insights, including our annual analyses of the largest pharmacies, specialtypharmacies, and PBMs. You can pay online using Visa, MasterCard, American Express, Discover, and PayPal. Didnt get it?
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content